Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bristol-Myers Squibb

Bristol-Myers Squibb?uq=3Oe4kK1Z
1887 FOUNDED
PUBLIC STATUS
20K-25K EMPLOYEES
BMY STOCK SYMBOL
46 INVESTMENTS
$52.43 SHARE PRICE (As of Tuesday Closing)
Description

Operator of a bio-pharmaceutical company designed to manufacture and discover innovative medicines. The company's pharmaceuticals operation discovers drugs for several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders, enabling the patients to avail effective medication for fighting against chronic disease.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Stock Exchange
NYS
Primary Office
  • 345 Park Avenue
  • New York, NY 10154
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bristol-Myers Squibb’s full profile, request a free trial.

Bristol-Myers Squibb Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$48.83 - $68.98 $85.8B $52.58 $0.89 8.5M 1.63B

Bristol-Myers Squibb Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 102,719,919 101,748,957 99,100,678 116,315,190
Revenue 22,037,000 20,776,000 19,427,000 16,560,000
EBITDA 6,009,000 6,116,000 6,464,000 2,637,000
Net Income 1,432,000 1,007,000 4,457,000 1,565,000
Total Assets 33,734,000 33,551,000 33,707,000 31,748,000
Total Debt 7,307,000 7,962,000 6,708,000 6,689,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bristol-Myers Squibb Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb‘s full profile, request access.

Request full access to PitchBook

Bristol-Myers Squibb Investments & Acquisitions (46)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 26-Oct-2018 00000 00000 00 0000 Drug Discovery
00000000 12-Oct-2018 0000 0000 Drug Delivery 00000 0000000 00
000000 00000000000 08-Aug-2018 0000 00.000 Biotechnology
000 000 19-Jul-2018 00000 00000 00 000.00 Drug Discovery
Enterome 04-Jan-2018 Later Stage VC 000.00 Drug Discovery 0000 000 000000000
To view this company’s complete investment and acquisition history, request access »

Bristol-Myers Squibb Exits (12)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 20-Jun-2011 00000 00000 00 0000 Completed
  • 0000000-00000 0000
000000 05-Aug-2009 00000 00000 00 000.00 Completed
  • 9 buyers
00000 00000000000 14-Nov-2007 00000 00000 00 000.00 Completed
  • 15 buyers
0000000000 17-Oct-2003 00000 00000 00 0000 Completed
  • 4 buyers
ImClone Systems 01-Sep-2001 Secondary Transaction - Private 000 Completed
To view this company’s complete exits history, request access »

Bristol-Myers Squibb Subsidiaries (7)

Company Name Industry Location Founded
IFM Therapeutics Drug Discovery Boston, MA 2015
0000000 Drug Discovery Copenhagen North, Denmark 0000
000000000 Drug Discovery Lexington, MA 0000
0000000-00000 0000 Foundation New York, NY 0000
000000000000 Drug Discovery Seattle, WA 0000
To view this company’s complete subsidiary history, request access »

Bristol-Myers Squibb Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bristol-Myers Squibb‘s full profile, request access.

Request full access to PitchBook

Bristol-Myers Squibb Executive Team (41)

Name Title Board
Seat
Contact
Info
Giovanni Caforio MD Chairman of the Board and Chief Executive Officer
Charles Bancroft Executive Vice President, Chief Financial Officer and Global Business Operations
Ann Judge Senior Vice President and Chief Human Resources Officer
Paul von Autenried Chief Information Officer & Senior Vice President
Thomas Lynch MD Executive Vice President & Chief Scientific Officer

16 Former Executives

You’re viewing 5 of 41 executives. Get the full list »

Bristol-Myers Squibb Board Members (8)

Name Representing Role Since Contact
Info
0000 0000 Self Board Member 000 0000
000000 0000000 Self Board Member 000 0000
00000000 0000000 00 Bristol-Myers Squibb Chairman of the Board and Chief Executive Officer 000 0000
00000 00000000 Self Board Member 000 0000
0000000 000000000 Self Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »